35
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effects of a Diagnosis-Related Group Payment Reform on Length and Costs of Hospitalization in Sichuan, China: A Synthetic Control Study

, ORCID Icon, , , &
Pages 1623-1637 | Received 23 Mar 2024, Accepted 05 Jun 2024, Published online: 03 Jul 2024

References

  • Organization WH. Global spending on health: rising to the pandemic’s challenges. Organization WH; 2022.
  • OECDiLibrary. Health at a glance 2023: OECD Indicators; 2023.
  • Commission H. The 2022 statistical communiqué on the development of health undertakings was released; 2023.
  • China’s health costs; 2022 Available from: https://www.ceicdata.com/zh-hans/china/expenditure-on-public-health. Accessed June 06, 2024.
  • China NHCotPsRo. China health statistical yearbook; 2023.
  • Ding Y, Yin J, Zheng C, Dixon S, Sun Q. The impacts of diagnosis-intervention packet payment on the providers’ behavior of inpatient care-evidence from a national pilot city in China. Front Public Health. 2023;11:1069131. doi:10.3389/fpubh.2023.1069131
  • Mathauer I, Wittenbecher F. Hospital payment systems based on diagnosis-related groups: experiences in low- and middle-income countries. Bull World Health Organ. 2013;91(10):746–756a. doi:10.2471/BLT.12.115931
  • Zhang L, Sun L. Impacts of diagnosis-related groups payment on the healthcare providers’ behavior in china: a cross-sectional study among physicians. Risk Manag Healthc Policy. 2021;14:2263–2276. doi:10.2147/RMHP.S308183
  • Liu R, Shi J, Yang B, et al. Charting a path forward: policy analysis of China’s evolved DRG-based hospital payment system. Int Health. 2017;9(5):317–324. doi:10.1093/inthealth/ihx030
  • Fetter RB, Shin Y, Freeman JL, Averill RF, Thompson JD. Case mix definition by diagnosis-related groups. Med Care. 1980;18(2 Suppl):1–53.
  • Annear PL, Kwon S, Lorenzoni L, et al. Pathways to DRG-based hospital payment systems in Japan, Korea, and Thailand. Health Policy. 2018;122(7):707–713. doi:10.1016/j.healthpol.2018.04.013
  • Peterson C, Xu L, Grosse SD, Florence C. Professional Fees for U.S. Hospital Care. Med Care. 2023;61(10):644–650. doi:10.1097/MLR.0000000000001900
  • Busse R, Geissler A, Aaviksoo A, et al. Diagnosis related groups in Europe: Moving towards transparency, efficiency, and quality in hospitals? BMJ. 2013;346:f3197.
  • Klein-Hitpaß U, Scheller-Kreinsen D. Policy trends and reforms in the German DRG-based hospital payment system. Health Policy. 2015;119(3):252–257. doi:10.1016/j.healthpol.2015.01.006
  • He AJ. Scaling-up through piloting: dual-track provider payment reforms in China’s health system. Health Policy Plan. 2023;38(2):218–227. doi:10.1093/heapol/czac080
  • Yip WC, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for health-care providers in China. Lancet. 2010;375(9720):1120–1130. doi:10.1016/S0140-6736(10)60063-3
  • Bureau PMP. National Pilot Work Programme on Payment by Disease Diagnosis-Related Grouping (DRG) in Panzhihua City. Bureau PMP; 2019.
  • Authority HI. Notice of the national healthcare security administration on printing and distributing the three-year action plan for the reform of DRG/DIP payment methods. 2021.
  • Abadie A, Gardeazabal J. The economic costs of conflict: A case study of the Basque country. Am Econ Rev. 2003;93(1):113–132. doi:10.1257/000282803321455188
  • News C. Notice of the national healthcare security administration on printing and distributing the three-year action plan for the reform of DRG/DIP Payment Methods. Auth HI. 2021;6.
  • Abadie A, Diamond A, Hainmueller J. Comparative politics and the synthetic control method. Am J Political Sci. 2012;59.
  • Kreif N, Grieve R, Hangartner D, Turner AJ, Nikolova S, Sutton M. Examination of the synthetic control method for evaluating health policies with multiple treated units. Health Econ. 2016;25(12):1514–1528. doi:10.1002/hec.3258
  • Chen Q, Yan G. A mixed placebo test for synthetic control method. Econ Lett. 2023;224:111004. doi:10.1016/j.econlet.2023.111004
  • Britteon P, Fatimah A, Lau YS, et al. The effect of devolution on health: a generalised synthetic control analysis of Greater Manchester, England. Lancet Public Health. 2022;7(10):e844–e852. doi:10.1016/S2468-2667(22)00198-0
  • Li Q, Fan X, Jian W. Impact of diagnosis-related-group (DRG) payment on variation in hospitalization expenditure: evidence from China. BMC Health Serv Res. 2023;23(1):688. doi:10.1186/s12913-023-09686-z
  • Kutz A, Gut L, Ebrahimi F, Wagner U, Schuetz P, Mueller B. Association of the Swiss diagnosis-related group reimbursement system with length of stay, mortality, and readmission rates in hospitalized adult patients. JAMA Net Open. 2019;2(2):e188332. doi:10.1001/jamanetworkopen.2018.8332
  • Wang S, Wu N, Wang H, et al. Impacts of a new diagnosis-related group point payment system on children’s medical services in China: length of stay and costs. Int J Health Plann Manage. 2024;39:432–446. doi:10.1002/hpm.3739
  • Statistics SPBo. Statistical Communiqué on the National Economic and Social Development of Sichuan Province in 2023. Statistics SPBo; 2024.
  • Daily S The total industrial economy exceeded 1.5 trillion yuan; 2022.
  • Commission PMH Main Health Statistics of Panzhihua City in 2023; 2024.
  • Yan G, Chen Q. synth2: synthetic control method with placebo tests, robustness test, and visualization. Stata J. 2023;23(3):597–624. doi:10.1177/1536867X231195278
  • Abadie A, Diamond A, Hainmueller J. Synthetic control methods for comparative case studies: Estimating the effect of California’s tobacco control program. J Am Stat Assoc. 2010;105(490):493–505. doi:10.1198/jasa.2009.ap08746
  • Feng L, Tian Y, He M, et al. Impact of DRGs-based inpatient service management on the performance of regional inpatient services in Shanghai, China: an interrupted time series study, 2013-2019. BMC Health Serv Res. 2020;20(1):942. doi:10.1186/s12913-020-05790-6
  • Zeng JQ. The pilot results of 47 148 cases of BJ-DRGs-based payment in China. Int J Health Plann Manage. 2019;34(4):1386–1398. doi:10.1002/hpm.2818
  • Ostermann H, Bachner F, Habimana K. The Austrian DRG-system: Insights from the first 2 decades. European j Public Health. 2018;28.
  • Gonser P, Lotter O, Schaller HE, Jaminet P. Development of length of stay and reimbursement in elective hand surgery after the introduction of DRGs in Germany. Handchir Mikrochir Plast Chir. 2012;44(5):306–309. doi:10.1055/s-0032-1323712
  • Wu Y, Fung H, Shum HM, et al. Evaluation of length of stay, care volume, in-hospital mortality, and emergency readmission rate associated with use of diagnosis-related groups for internal resource allocation in public hospitals in Hong Kong. JAMA Net Open. 2022;5(2):e2145685. doi:10.1001/jamanetworkopen.2021.45685
  • Luo M-W, Xie S-W, Luo M-Y, Cheng X-Q, Yan J characteristics and related factors of length of stay and readmission rates of inpatients under a DRG based payment system: A cohort study; 2021.
  • Rosko MD, Broyles RW. Short-term responses of hospitals to the DRG prospective pricing mechanism in new Jersey. Med Care. 1987;25:88–99. doi:10.1097/00005650-198702000-00002
  • Yuan S, Liu W, Wei F, et al. Impacts of hospital payment based on diagnosis related groups (DRGs) with global budget on resource use and quality of care: a case study in China. Iran J Public Health. 2019;48(2):238–246.
  • Xiang X, Dong L, Qi M, Wang H. How does diagnosis-related group payment impact the health care received by rural residents? Lessons learned from China. Public Health. 2024;232:68–73. doi:10.1016/j.puhe.2024.04.021
  • S-s C, Xiao D, Cheng Q, et al. Hospitalization time and outcome in patients with Coronavirus Disease 2019 (COVID-19): analysis data from China. SSRN Electron J. 2020.
  • X-Z L, Jin F, Zhang J-G, et al. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect Dis Pov. 2020;9. doi:10.1186/s40249-020-00689-0
  • Mickael Bech BH. Rasmus Trap Wolf. Alternative styrings- og afregningsmodeller for sygehuse med afsæt i værdibaseret styring. En kortlægning af regionale forsøg og ordninger. KORA, Det Nationale Institut Kommuners Og Regioners Analyse Og Forskning. 2017.
  • Science in Healthcare: Delivering the NHS Long Term Plan – The Chief Scientific Officer’s Strategy. Healthcare science LTP; 2020.
  • Réforme des modes de financement et de régulation. Available from: https://sante.gouv.fr/ministere/documentation-et-publications-officielles/rapports/sante/article/rapport-reforme-des-modes-de-financement-et-de-regulation.Accessed. Accessed June 06, 2024
  • Wang W, Liang J, Fan R, Cai Y, Yin B, Hu Y. Impact of medical-pharmaceutical separation reform on hospitalization expenditure in tertiary public hospitals: difference-in-difference analysis based on panel data from Beijing. Risk Manag Healthc Policy. 2024;17:1263–1276. doi:10.2147/RMHP.S456953